Login Register Cart 0
Generic placeholder image

Current Biotechnology

Editor-in-Chief

ISSN (Print): 2211-5501
ISSN (Online): 2211-551X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Oral Toxicity Studies, Histopathology, and Anti-Diabetic Activity of Polyherbal Extract in STZ Induced Diabetes in Rats

Author(s): Pranay Wal*, Nikita Saraswat, Ankita Wal, Rashmi Saxena Pal and Deepa Maurya

Volume 11, Issue 1, 2022

Published on: 20 May, 2022

Page: [51 - 59] Pages: 9

DOI: 10.2174/2211550111666211220165802

Price: $65

Abstract

Background: Diabetes mellitus is a disease and endocrine disorder. It is a growing health problem in various countries. The prevalence of diabetes is rising worldwide; around 5.4% rise in patients with diabetes is expected by 2025. The World Health Organization (WHO) has reported that 173 million adults are suffering from diabetes mellitus in developing counties. In this research, estimation of glucose levels was performed in Wistar rats post-induction of diabetes by streptozotocin. Metformin has been used as a standard dose for treatment. This study demonstrated the acute oral toxicity and subacute oral toxicity of ethanolic extract of Saraca asoca leaves and Asparagus racemosus roots and evaluated the antidiabetic activity.

Objective: This study aimed to evaluate the acute toxicity and sub-acute toxicity of the polyherbal ethanolic extract on vital organs. The visible changes in the organs of each group of Wistar rats were also determined in this study. Moreover, the hypoglycaemic action of the polyherbal extract of Saraca asoca and Asparagus racemosus was also explored.

Methods: Wistar rats were divided into four groups for assessing acute oral toxicity. Groups were administered doses of 5,50, 300, and 2000mg/kg body weight of the polyherbal extract. Subacute oral toxicity studies were performed by administering a polyherbal extract of 250, 500, 1000mg/kg body weight. For evaluating the antidiabetic activity, animals were divided into 5 groups. In group 1 (normal control), saline was administered; in group 2, standard drug Metformin was administered; in group 3, no drug was given to rats with diabetes (Streptozotocin-Induced diabetic with 150mg/kg body weight), thus forming the diseased group. In group 4, ethanolic extract with 100mg/kg group was administered, and in group 5, ethanolic extract of 200mg/kg was administered. On the last day, the blood glucose levels and body weights of rats were examined. Histopathology studies were conducted by sacrificing the animals, isolating the organs, such as tissue pancreas, spleen, heart, lungs, liver, and kidney, and placing them on slides using a microscopic examination. Data were selected by searching the articles in the databases, such as NCBI, Web of Science and ScienceDirect, and PubMed from 1989 to 2020 by using keywords, such as “Antidiabetic,” “Saraca indica,” “Asparagus racemosus,” “ethanolic polyherbal extract,” “oral toxicity study,” “histopathology,” and “Streptozotocin.”

Results: The polyherbal ethanolic extract of Saraca asoca and Asparagus racemosus at a dose of 100 mg/kg and 200 mg/kg showed better effects against streptozotocin-induced diabetic rats having 150 mg/kg body weight. Regarding acute toxicity and subacute oral toxicity studies, all the extracts showed significant values (P <0.05) and were found to be safe and non-toxic. The body weight was also improved; no inflammation and erosion were seen on any organs of the Wistar rat in a histopathology analysis.

Conclusion: The polyherbal ethanolic extract of Saraca asoca and Asparagus racemosus showed hypoglycaemic activity against STZ-induced diabetes in experimental Wistar rats. The results showed the beneficial effects of these ethanolic extracts, improving the body weight and changes in lipid metabolism and protecting the organs of Wistar rats, such as the liver, kidney, spleen, pancreas, lungs, and heart, against impairment of blood glucose. All organs were weighted, tissues from organs were isolated, then stained using eosin dye, and changes were observed by microscopy photos. No signs of inflammation and erosion were reported at the end of the study, indicating the healing action of the extract.

Keywords: Antidiabetic, Saraca indica, Asparagus racemosus, ethanolic polyherbal extract, oral toxicity study, histopathology, streptozotocin.

« Previous Next »
Graphical Abstract

[1]
Parasuraman S, Thing GS, Dhanaraj SA. Polyherbal formulation: Concept of ayurveda. Pharmacogn Rev 2014; 8(16): 73-80.
[http://dx.doi.org/10.4103/0973-7847.134229] [PMID: 25125878]
[2]
Chiappelli F, Prolo P, Rosenblum M, Edgerton M, Cajulis OS. Evidence-based research in complementary and alternative medicine II: the process of evidence-based research. Evid Based Complement Alternat Med 2006; 3(1): 3-12.
[http://dx.doi.org/10.1093/ecam/nek017] [PMID: 16550218]
[3]
Firenzuoli F, Gori L. Herbal medicine today: Clinical and research issues. Evid Based Complement Alternat Med 2007; 4(s1)(Suppl. 1): 37-40.
[http://dx.doi.org/10.1093/ecam/nem096] [PMID: 18227931]
[4]
AL-Asiri IS, Alotaibi F. Predictors of depression among diabetes mellitus outpatient attending king Abdul-Aziz specialist hospital in Taif, Saudi Arabia. Int J Pharm Res Allied Sci 2018; 7(4): 97-103.
[5]
Zelensky VA, Rzhepakovsky IV, Anfinogenova OI. Application of laboratory and X-Ray general studies un early diagnostics of metabolic disturbances of bone tissue in children with autoimmune diabetes mellitus. Entomol Appl Sci Lett 2018; 5(4): 1-12.
[6]
Priyadi A, Muhtadi A, Suwantika AA, Sumiwi SA. An economic evaluation of diabetes mellitus management in South East Asia. J Adv Pharm Educ Res 2019; 9(2): 53-74.
[7]
Chukwuma CI, Matsabisa MG, Ibrahim MA, Erukainure OL, Chabalala MH, Islam MS. Medicinal plants with concomitant anti-diabetic and anti-hypertensive effects as potential sources of dual acting therapies against diabetes and hypertension: A review. J Ethnopharmacol 2019; 235: 329-60.
[8]
Yang JH, Lee SH, Heo YT, Uhm SJ, Lee HT. Generation of insulin-producing cells from gnotobiotic porcine skin-derived stem cells. Biochem Biophys Res Commun 2010; 397(4): 679-84.
[http://dx.doi.org/10.1016/j.bbrc.2010.05.158] [PMID: 20594970]
[9]
Defronzo RA. Pathogenesis of type 2 diabetes: Metabolic and molecular implications for identifying diabetes genes. Diabetes Rev (Alex) 1997; 5: 177-269.
[10]
Choi SB, Lee JH, Lee JH, et al. Improvement of β-cell function after achievement of optimal glycaemic control via long-term continuous subcutaneous insulin infusion therapy in non-newly diagnosed type 2 diabetic patients with suboptimal glycaemic control. Diabetes Metab Res Rev 2013; 29(6): 473-82.
[http://dx.doi.org/10.1002/dmrr.2416] [PMID: 23592489]
[11]
Harris M. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes 1979; 28(12): 1039-57.
[12]
Franklin EB, Crisler SC, Shappley R, Armour MM, McCommon DT, Robert RF. Real-time support of pediatric diabetes self-care by a transport team. Diabetes Care 2014; 37(1): 81-90.
[PMID: 23959568]
[13]
Bopana N, Saxena S. Asparagus racemosus--ethnopharmacological evaluation and conservation needs. J Ethnopharmacol 2007; 110(1): 1-15.
[http://dx.doi.org/10.1016/j.jep.2007.01.001] [PMID: 17240097]
[14]
Verma S, Gupta M, Popli H, Aggarwal G. Diabetes mellitus treatment using herbal drugs. Int J Phytomed 2018; 10(1): 1-10.
[http://dx.doi.org/10.5138/09750185.2181]
[15]
Kumar S, Narwal S, Kumar D, Singh G, Narwal S, Arya R. Evaluation of antihyperglycemic and antioxidant activities of Saraca asoca (Roxb.) De Wild leaves in streptozotocin-induced diabetic mice. Asian Pac J Trop Dis 2012; 2(3): 170-6.
[16]
Pradhan P, Joseph L. Saraca asoca (Ashoka): A review. J Chem Pharm Res 2009; 1(1): 62-71.
[17]
Gogte VM. Ayurvedic pharmacology and therapeutic uses of medicinal plants. Mumbai: SPARC 2000.
[18]
Frawley D. Ayurvedic Healing-a Comprehensive Guide. Delhi: Motilal Banarsidass Publishers Private Limited 1997.
[19]
Bapodara M, Nagani K, Chanda S. Pharmacognostic and physicochemical study of Punica granatum L. leaf. Pharmacogn J 2011; 3: 29-32.
[http://dx.doi.org/10.5530/pj.2011.21.5]
[20]
Khandelwal KR. Practical Pharmacognosy. Nirali Publication Pune 2008.
[21]
OECD. Test No 423: Acute oral toxicity Acute toxic class method, OECD Guidelines for the testing of chemical. Section 4, OECD Pub-lishing: Paris 2002.
[22]
OECD. Test 407: Repeated dose 28-days oral toxicity study in rodents OECD Guidelines for the Testing of Chemical. Section 4, OECD publishing: Paris, 2008.
[23]
Abebaw M, Mishra B, Gelayee DA. Evaluation of anti-ulcer activity of the leaf extract of Osyris quadripartita Decne. (Santalaceae) in rats. J Exp Pharmacol 2017; 9: 1-11.
[http://dx.doi.org/10.2147/JEP.S125383] [PMID: 28144167]
[24]
Al-Afifi NA, Alabsi AM, Bakri MM, Ramanathan A. Acute and sub-acute oral toxicity of Dracaena cinnabari resin methanol extract in rats. BMC Complement Altern Med 2018; 18(1): 50.
[http://dx.doi.org/10.1186/s12906-018-2110-3] [PMID: 29402248]
[25]
Kifayatullah M, Mustafa MS, Sengupta P, Sarker MMR, Das A, Das SK. Evaluation of the acute and sub-acute toxicity of the ethanolic extract of Pericampylus glaucus (Lam.) Merr. in BALB/c mice. J Acute Dis 2015; 4(4): 309-15.
[http://dx.doi.org/10.1016/j.joad.2015.06.010]
[26]
Shende P, Kulkarni YA, Gaud RS, et al. Acute and repeated dose toxicity studies of different β-cyclodextrin-based nanosponge formula-tions. J Pharm Sci 2015; 104(5): 1856-63.
[http://dx.doi.org/10.1002/jps.24416] [PMID: 25754724]
[27]
Unuofin JO, Otunola GA, Afolayan AJ. Evaluation of acute and subacute toxicity of whole-plant aqueous extract of Vernonia mespilifolia Less. in Wistar rats. J Integr Med 2018; 16(5): 335-41.
[http://dx.doi.org/10.1016/j.joim.2018.07.003] [PMID: 30007829]

Rights & Permissions Print Cite
Article Metrics
11
1
© 2024 Bentham Science Publishers | Privacy Policy